News Conference News EAS 2020 Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank Michael O'Riordan October 07, 2020
News Daily News More Insights Into AAA Genetics Spur New Questions on Screening Caitlin E. Cox September 29, 2020
News Daily News Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD Michael O'Riordan September 22, 2020
News Daily News LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes Yael L. Maxwell September 14, 2020
News Conference News ESC 2020 EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression Yael L. Maxwell September 02, 2020
News Daily News Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated Yael L. Maxwell August 27, 2020
News Daily News Could Statins Curb Fatal or Severe COVID-19? Some Clues Michael O'Riordan August 14, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins L.A. McKeown August 04, 2020
News Daily News PAD Patients Undertreated With Statins Despite Elevated CV Risk L.A. McKeown July 13, 2020
News Daily News Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE Michael O'Riordan July 08, 2020
News Daily News Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data Yael L. Maxwell July 07, 2020
News Daily News Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly Michael O'Riordan July 06, 2020
News Daily News AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives Yael L. Maxwell May 29, 2020
News Conference News SCAI 2020 Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data Caitlin E. Cox May 15, 2020
News Daily News Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans Michael O'Riordan May 15, 2020
News Daily News FOURIER Surveys Reassure About Cognitive Safety of Evolocumab Todd Neale May 06, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020
News Daily News Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention Yael L. Maxwell April 28, 2020
News Conference News ACC 2020 Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH Yael L. Maxwell April 06, 2020